US 8841260
Methods and compositions for treating Huntington's Disease
granted A61KA61K38/1709A61P
Quick answer
US patent 8841260 (Methods and compositions for treating Huntington's Disease) held by Sangamo Biosciences, Inc. expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/1709, A61P, A61P25/14, A61P43/00